Massey Ventures and the Gillies McIndoe Research Institute have reached an agreement with AFT Pharmaceuticals to develop a topical treatment for keloid and hypertrophic scarring.
AFT - Maxigesic IV launched in the United States sharechat.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharechat.co.nz Daily Mail and Mail on Sunday newspapers.
AFT broadens R&D pipeline with new product candidate sharechat.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sharechat.co.nz Daily Mail and Mail on Sunday newspapers.